Vivodyne announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos...
Read more
Vivodyne announced today that it has expanded its executive team with Dr. Susan Billings joining as its Chief Commercial...
Read more
Center for Contemporary Sciences (CCS) Applauds the Senate for Passing the FDA Modernization Act 2.0
The U.S. Senate unanimously passed the FDA Modernization Act 2.0, S.5002 on September 28. As we shared last month,...
Read more
Dr. Jane Goodall and Vivodyne announced that they have delivered a letter to Congress urging its inclusion of the...
Read more
Vivodyne has been named #1 in the list of Fast Company’s World’s Most Innovative “Small but Mighty” Companies for 2022. This...
Read more
Vivodyne's goal is to lower the bar for labs and scientists to test their own research. This Penn-founded biotech...
Read more
Vivodyne, a startup developing a new bio-pharma discovery pipeline that starts and ends in lab-grown human tissues, announced today...
Read more